One fail and one success, should it be accepted? [Regulatives / Guidelines]

posted by jag009  – NJ, 2019-07-18 19:14 (644 d 18:36 ago) – Posting: # 20394
Views: 1,693

» Dear guys,
» We did a BE trial using a partial replicated design(TRR,RTR,RRT), but it was fail to demonstrate BE because the Cmax of one subject after administration of test drug was too much higher than reference drug, and when excluding the data of this subject, the results showed bioequivalent. But actually there were no reason to exclude the data from this subject.
» And we conducted another BE trial, this time using full replicated design(TRTR,RTRT), and this time the result showed bioequivalent.

What about AUC from that subject?


Complete thread:

 Admin contact
21,429 posts in 4,479 threads, 1,512 registered users;
online 13 (0 registered, 13 guests [including 2 identified bots]).
Forum time: Friday 13:50 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz